Boston Scientific has made major strides in cleaning up its act, and the Street has certainly noticed.
Diagnostics have been taking off around health care, from fast risers like Illumina to tried-and-true companies like Thermo-Fisher. Don't miss out on this health boom.
In this week's edition, we'll add two dividend-paying stalwarts, Johnson & Johnson and Abbott Labs, to our HealthyMoney CAPS virtual portfolio.
Boston Scientific's stock has roared higher in 2013, but are dangers awaiting investors ahead?
What should investors expect from AbbVie when it reports third quarter earnings on Friday?
With growth opportunities dwindling, should Intuitive Surgical join Stryker and Medtronic in paying a dividend?
Can Stryker keep outperforming the market by tapping into new opportunities in emerging markets and robotic surgeries?
Lawmakers fought a big battle over defunding Obamacare as part of the controversy over the government shutdown. But do you understand what it would really mean to defund Obamacare? We've got the answers you need to understand what taking funding away from the Affordable Care Act would actually do to you and millions of Americans.
Intuitive Surgical cited a lack of demand for its Da Vinci surgical systems for its disappointing results today. Would Obamacare's success actually help Intuitive Surgical and MAKO Surgical?
Here's the low-down on Intuitive Surgical's disappointing earnings release.